Parameshwar J, Poole-Wilson P A
National Heart and Lung Institute, London, U.K.
Eur Heart J. 1993 Jul;14 Suppl A:38-44. doi: 10.1093/eurheartj/14.suppl_a.38.
Calcium antagonists have been widely used for the treatment of angina and hypertension. Because of vasodilator and anti-ischaemic properties, calcium antagonists might be expected to bring benefit to patients with heart failure, particularly when the heart failure is due to coronary heart disease. Eight trials of calcium antagonists, fulfilling specific criteria, have been reviewed. The evidence at present does not support the use of calcium antagonists in established heart failure. Some benefit may accure from the use of the newer calcium antagonists but further trials are awaited. Calcium antagonists appear to improve diastolic fraction in patients with coronary heart disease, no overt heart failure but a reduced ejection fraction.
钙拮抗剂已被广泛用于治疗心绞痛和高血压。由于其血管舒张和抗缺血特性,钙拮抗剂可能会给心力衰竭患者带来益处,尤其是当心力衰竭由冠心病引起时。已对八项符合特定标准的钙拮抗剂试验进行了综述。目前的证据不支持在已确诊的心力衰竭中使用钙拮抗剂。使用新型钙拮抗剂可能会有一些益处,但仍有待进一步试验。钙拮抗剂似乎能改善冠心病患者的舒张分数,这些患者没有明显心力衰竭但射血分数降低。